Cannabis	B:C3160814
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
:	O
A	O
cross-sectional	O
study	I:C0010362
.	O

Cannabis	O
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
:	O
A	O
cross-sectional	O
study	I:C0010362
.	O

Cannabis	O
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
:	O
A	O
cross-sectional	B:C0010362
study	I:C0010362
.	O

Cannabis	B:C3160814
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
obesity	O
and	O
diabetes	O
mellitus	I:C0011849
(	O
diabetes	O
mellitus	I:C0011849
)	O
in	O
humans	O
and	O
mouse	O
disease	O
models	I:C0684309
.	O

Cannabis	O
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
obesity	B:C0028754
and	O
diabetes	O
mellitus	I:C0011849
(	O
diabetes	O
mellitus	I:C0011849
)	O
in	O
humans	O
and	O
mouse	O
disease	O
models	I:C0684309
.	O

Cannabis	O
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
obesity	O
and	O
diabetes	B:C0011849
mellitus	I:C0011849
(	O
diabetes	O
mellitus	I:C0011849
)	O
in	O
humans	O
and	O
mouse	O
disease	O
models	I:C0684309
.	O

Cannabis	O
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
obesity	O
and	O
diabetes	O
mellitus	I:C0011849
(	O
diabetes	B:C0011849
mellitus	I:C0011849
)	O
in	O
humans	O
and	O
mouse	O
disease	O
models	I:C0684309
.	O

Cannabis	O
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
obesity	O
and	O
diabetes	O
mellitus	I:C0011849
(	O
diabetes	O
mellitus	I:C0011849
)	O
in	O
humans	B:C0086418
and	O
mouse	O
disease	O
models	I:C0684309
.	O

Cannabis	O
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
obesity	O
and	O
diabetes	O
mellitus	I:C0011849
(	O
diabetes	O
mellitus	I:C0011849
)	O
in	O
humans	O
and	O
mouse	B:C0026809
disease	O
models	I:C0684309
.	O

Cannabis	O
use	I:C3160814
is	O
associated	O
with	O
reduced	O
prevalence	O
of	O
obesity	O
and	O
diabetes	O
mellitus	I:C0011849
(	O
diabetes	O
mellitus	I:C0011849
)	O
in	O
humans	O
and	O
mouse	O
disease	B:C0684309
models	I:C0684309
.	O

Obesity	B:C0028754
and	O
diabetes	O
mellitus	I:C0011849
are	O
a	O
well	O
-	O
established	O
independent	O
risk	O
factor	O
for	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
,	O
the	O
most	O
prevalent	O
liver	O
disease	I:C0023895
globally	O
.	O

Obesity	O
and	O
diabetes	B:C0011849
mellitus	I:C0011849
are	O
a	O
well	O
-	O
established	O
independent	O
risk	O
factor	O
for	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
,	O
the	O
most	O
prevalent	O
liver	O
disease	I:C0023895
globally	O
.	O

Obesity	O
and	O
diabetes	O
mellitus	I:C0011849
are	O
a	O
well	O
-	O
established	O
independent	O
risk	O
factor	O
for	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
,	O
the	O
most	O
prevalent	O
liver	O
disease	I:C0023895
globally	O
.	O

Obesity	O
and	O
diabetes	O
mellitus	I:C0011849
are	O
a	O
well	O
-	O
established	O
independent	O
risk	O
factor	O
for	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
,	O
the	O
most	O
prevalent	O
liver	O
disease	I:C0023895
globally	O
.	O

Obesity	O
and	O
diabetes	O
mellitus	I:C0011849
are	O
a	O
well	O
-	O
established	O
independent	O
risk	O
factor	O
for	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
,	O
the	O
most	O
prevalent	O
liver	B:C0023895
disease	I:C0023895
globally	O
.	O

The	O
effects	O
of	O
cannabis	B:C3160814
use	I:C3160814
on	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
in	O
humans	O
remains	O
ill	O
-	I:C2047937
defined	I:C2047937
.	O

The	O
effects	O
of	O
cannabis	O
use	I:C3160814
on	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
in	O
humans	O
remains	O
ill	O
-	I:C2047937
defined	I:C2047937
.	O

The	O
effects	O
of	O
cannabis	O
use	I:C3160814
on	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
in	O
humans	B:C0086418
remains	O
ill	O
-	I:C2047937
defined	I:C2047937
.	O

The	O
effects	O
of	O
cannabis	O
use	I:C3160814
on	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
in	O
humans	O
remains	O
ill	B:C2047937
-	I:C2047937
defined	I:C2047937
.	O

Our	O
objective	B:C0018017
is	O
to	O
determine	O
the	O
relationship	O
between	O
cannabis	O
use	I:C3160814
and	O
the	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
in	O
humans	O
.	O

Our	O
objective	O
is	O
to	O
determine	O
the	O
relationship	O
between	O
cannabis	B:C3160814
use	I:C3160814
and	O
the	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
in	O
humans	O
.	O

Our	O
objective	O
is	O
to	O
determine	O
the	O
relationship	O
between	O
cannabis	O
use	I:C3160814
and	O
the	O
prevalence	O
of	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
in	O
humans	O
.	O

Our	O
objective	O
is	O
to	O
determine	O
the	O
relationship	O
between	O
cannabis	O
use	I:C3160814
and	O
the	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
in	O
humans	B:C0086418
.	O

We	O
conducted	O
a	O
population	B:C0007328
-	I:C0007328
based	I:C0007328
case	I:C0007328
-	I:C0007328
control	I:C0007328
study	I:C0007328
of	O
5,950,391	O
patients	O
using	O
the	O
2014	O
Healthcare	O
Cost	O
and	O
Utilization	O
Project	O
(	O
HCUP	O
)	O
,	O
Nationwide	O
Inpatient	I:C0038951
Survey	I:C0038951
(	O
Nationwide	O
Inpatient	I:C0038951
Survey	I:C0038951
)	O
discharge	O
records	I:C0743221
of	O
patients	O
18	O
years	O
and	O
older	O
.	O

We	O
conducted	O
a	O
population	O
-	I:C0007328
based	I:C0007328
case	I:C0007328
-	I:C0007328
control	I:C0007328
study	I:C0007328
of	O
5,950,391	O
patients	O
using	O
the	O
2014	O
Healthcare	O
Cost	O
and	O
Utilization	O
Project	O
(	O
HCUP	O
)	O
,	O
Nationwide	B:C0038951
Inpatient	I:C0038951
Survey	I:C0038951
(	O
Nationwide	O
Inpatient	I:C0038951
Survey	I:C0038951
)	O
discharge	O
records	I:C0743221
of	O
patients	O
18	O
years	O
and	O
older	O
.	O

We	O
conducted	O
a	O
population	O
-	I:C0007328
based	I:C0007328
case	I:C0007328
-	I:C0007328
control	I:C0007328
study	I:C0007328
of	O
5,950,391	O
patients	O
using	O
the	O
2014	O
Healthcare	O
Cost	O
and	O
Utilization	O
Project	O
(	O
HCUP	O
)	O
,	O
Nationwide	O
Inpatient	I:C0038951
Survey	I:C0038951
(	O
Nationwide	B:C0038951
Inpatient	I:C0038951
Survey	I:C0038951
)	O
discharge	O
records	I:C0743221
of	O
patients	O
18	O
years	O
and	O
older	O
.	O

We	O
conducted	O
a	O
population	O
-	I:C0007328
based	I:C0007328
case	I:C0007328
-	I:C0007328
control	I:C0007328
study	I:C0007328
of	O
5,950,391	O
patients	O
using	O
the	O
2014	O
Healthcare	O
Cost	O
and	O
Utilization	O
Project	O
(	O
HCUP	O
)	O
,	O
Nationwide	O
Inpatient	I:C0038951
Survey	I:C0038951
(	O
Nationwide	O
Inpatient	I:C0038951
Survey	I:C0038951
)	O
discharge	B:C0743221
records	I:C0743221
of	O
patients	O
18	O
years	O
and	O
older	O
.	O

After	O
identifying	O
patients	O
with	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
1	O
%	O
of	O
all	O
patients	O
)	O
,	O
we	O
next	O
identified	O
three	O
exposure	O
groups	I:C1257890
:	O
non-cannabis	O
users	I:C1706077
(	O
98.04	O
%	O
)	O
,	O
non-dependent	O
cannabis	I:C1706077
users	I:C1706077
(	O
1.74	O
%	O
)	O
,	O
and	O
dependent	O
cannabis	I:C1706077
users	I:C1706077
(	O
0.22	O
%	O
)	O
.	O

After	O
identifying	O
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
1	O
%	O
of	O
all	O
patients	O
)	O
,	O
we	O
next	O
identified	O
three	O
exposure	B:C1257890
groups	I:C1257890
:	O
non-cannabis	O
users	I:C1706077
(	O
98.04	O
%	O
)	O
,	O
non-dependent	O
cannabis	I:C1706077
users	I:C1706077
(	O
1.74	O
%	O
)	O
,	O
and	O
dependent	O
cannabis	I:C1706077
users	I:C1706077
(	O
0.22	O
%	O
)	O
.	O

After	O
identifying	O
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
1	O
%	O
of	O
all	O
patients	O
)	O
,	O
we	O
next	O
identified	O
three	O
exposure	O
groups	I:C1257890
:	O
non-cannabis	B:C1706077
users	I:C1706077
(	O
98.04	O
%	O
)	O
,	O
non-dependent	O
cannabis	I:C1706077
users	I:C1706077
(	O
1.74	O
%	O
)	O
,	O
and	O
dependent	O
cannabis	I:C1706077
users	I:C1706077
(	O
0.22	O
%	O
)	O
.	O

After	O
identifying	O
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
1	O
%	O
of	O
all	O
patients	O
)	O
,	O
we	O
next	O
identified	O
three	O
exposure	O
groups	I:C1257890
:	O
non-cannabis	O
users	I:C1706077
(	O
98.04	O
%	O
)	O
,	O
non-dependent	B:C1706077
cannabis	I:C1706077
users	I:C1706077
(	O
1.74	O
%	O
)	O
,	O
and	O
dependent	O
cannabis	I:C1706077
users	I:C1706077
(	O
0.22	O
%	O
)	O
.	O

After	O
identifying	O
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
1	O
%	O
of	O
all	O
patients	O
)	O
,	O
we	O
next	O
identified	O
three	O
exposure	O
groups	I:C1257890
:	O
non-cannabis	O
users	I:C1706077
(	O
98.04	O
%	O
)	O
,	O
non-dependent	O
cannabis	I:C1706077
users	I:C1706077
(	O
1.74	O
%	O
)	O
,	O
and	O
dependent	B:C1706077
cannabis	I:C1706077
users	I:C1706077
(	O
0.22	O
%	O
)	O
.	O

We	O
adjusted	O
for	O
potential	O
demographics	O
and	O
patient	O
related	O
confounders	O
and	O
used	O
multivariate	O
logistic	O
regression	O
(	O
SAS	O
9.4	O
)	O
to	O
determine	O
the	O
odds	O
of	O
developing	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
with	O
respects	O
to	O
cannabis	O
use	I:C3160814
.	O

We	O
adjusted	O
for	O
potential	O
demographics	O
and	O
patient	O
related	O
confounders	O
and	O
used	O
multivariate	O
logistic	O
regression	O
(	O
SAS	O
9.4	O
)	O
to	O
determine	O
the	O
odds	O
of	O
developing	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
with	O
respects	O
to	O
cannabis	B:C3160814
use	I:C3160814
.	O

Our	O
findings	B:C0243095
revealed	O
that	O
cannabis	O
users	O
(	O
dependent	O
and	O
non-dependent	O
)	O
showed	O
significantly	O
lower	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
compared	O
to	O
non-users	O
(	O
AOR	O
:	O
0.82[0.76-0.88	O
]	O
;	O
p<0.0001	O
)	O
.	O

Our	O
findings	O
revealed	O
that	O
cannabis	B:C0024808
users	O
(	O
dependent	O
and	O
non-dependent	O
)	O
showed	O
significantly	O
lower	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
compared	O
to	O
non-users	O
(	O
AOR	O
:	O
0.82[0.76-0.88	O
]	O
;	O
p<0.0001	O
)	O
.	O

Our	O
findings	O
revealed	O
that	O
cannabis	O
users	B:C1706077
(	O
dependent	O
and	O
non-dependent	O
)	O
showed	O
significantly	O
lower	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
compared	O
to	O
non-users	O
(	O
AOR	O
:	O
0.82[0.76-0.88	O
]	O
;	O
p<0.0001	O
)	O
.	O

Our	O
findings	O
revealed	O
that	O
cannabis	O
users	O
(	O
dependent	O
and	O
non-dependent	B:C0243095
)	O
showed	O
significantly	O
lower	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
compared	O
to	O
non-users	O
(	O
AOR	O
:	O
0.82[0.76-0.88	O
]	O
;	O
p<0.0001	O
)	O
.	O

Our	O
findings	O
revealed	O
that	O
cannabis	O
users	O
(	O
dependent	O
and	O
non-dependent	O
)	O
showed	O
significantly	O
lower	B:C0441994
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
compared	O
to	O
non-users	O
(	O
AOR	O
:	O
0.82[0.76-0.88	O
]	O
;	O
p<0.0001	O
)	O
.	O

Our	O
findings	O
revealed	O
that	O
cannabis	O
users	O
(	O
dependent	O
and	O
non-dependent	O
)	O
showed	O
significantly	O
lower	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
compared	O
to	O
non-users	O
(	O
AOR	O
:	O
0.82[0.76-0.88	O
]	O
;	O
p<0.0001	O
)	O
.	O

Our	O
findings	O
revealed	O
that	O
cannabis	O
users	O
(	O
dependent	O
and	O
non-dependent	O
)	O
showed	O
significantly	O
lower	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
prevalence	O
compared	O
to	O
non-users	B:C1706077
(	O
AOR	O
:	O
0.82[0.76-0.88	O
]	O
;	O
p<0.0001	O
)	O
.	O

The	O
prevalence	O
of	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
was	O
15	O
%	O
lower	O
in	O
non-dependent	O
users	I:C1706077
(	O
AOR	O
:	O
0.85[0.79-0.92	O
]	O
;	O
p<0.0001	O
)	O
and	O
52	O
%	O
lower	O
in	O
dependent	O
users	I:C1706077
(	O
AOR	O
:	O
0.49[0.36-0.65	O
]	O
;	O
p<0.0001	O
)	O
.	O

The	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
was	O
15	O
%	O
lower	B:C0441994
in	O
non-dependent	O
users	I:C1706077
(	O
AOR	O
:	O
0.85[0.79-0.92	O
]	O
;	O
p<0.0001	O
)	O
and	O
52	O
%	O
lower	O
in	O
dependent	O
users	I:C1706077
(	O
AOR	O
:	O
0.49[0.36-0.65	O
]	O
;	O
p<0.0001	O
)	O
.	O

The	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
was	O
15	O
%	O
lower	O
in	O
non-dependent	B:C1706077
users	I:C1706077
(	O
AOR	O
:	O
0.85[0.79-0.92	O
]	O
;	O
p<0.0001	O
)	O
and	O
52	O
%	O
lower	O
in	O
dependent	O
users	I:C1706077
(	O
AOR	O
:	O
0.49[0.36-0.65	O
]	O
;	O
p<0.0001	O
)	O
.	O

The	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
was	O
15	O
%	O
lower	O
in	O
non-dependent	O
users	I:C1706077
(	O
AOR	O
:	O
0.85[0.79-0.92	O
]	O
;	O
p<0.0001	O
)	O
and	O
52	O
%	O
lower	B:C0441994
in	O
dependent	O
users	I:C1706077
(	O
AOR	O
:	O
0.49[0.36-0.65	O
]	O
;	O
p<0.0001	O
)	O
.	O

The	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
was	O
15	O
%	O
lower	O
in	O
non-dependent	O
users	I:C1706077
(	O
AOR	O
:	O
0.85[0.79-0.92	O
]	O
;	O
p<0.0001	O
)	O
and	O
52	O
%	O
lower	O
in	O
dependent	B:C1706077
users	I:C1706077
(	O
AOR	O
:	O
0.49[0.36-0.65	O
]	O
;	O
p<0.0001	O
)	O
.	O

Among	O
cannabis	B:C0024808
users	O
,	O
dependent	O
patients	O
had	O
43	O
%	O
significantly	O
lower	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
compared	O
to	O
non-dependent	O
patients	O
(	O
AOR	O
:	O
0.57[0.42-0.77	O
]	O
;	O
p<0.0001	O
)	O
.	O

Among	O
cannabis	O
users	B:C1706077
,	O
dependent	O
patients	O
had	O
43	O
%	O
significantly	O
lower	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
compared	O
to	O
non-dependent	O
patients	O
(	O
AOR	O
:	O
0.57[0.42-0.77	O
]	O
;	O
p<0.0001	O
)	O
.	O

Among	O
cannabis	O
users	O
,	O
dependent	O
patients	O
had	O
43	O
%	O
significantly	O
lower	O
prevalence	O
of	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
compared	O
to	O
non-dependent	O
patients	O
(	O
AOR	O
:	O
0.57[0.42-0.77	O
]	O
;	O
p<0.0001	O
)	O
.	O

Our	O
observations	B:C0302523
suggest	O
that	O
cannabis	O
use	I:C3160814
is	O
associated	O
with	O
lower	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
in	O
patients	O
.	O

Our	O
observations	O
suggest	O
that	O
cannabis	B:C3160814
use	I:C3160814
is	O
associated	O
with	O
lower	O
prevalence	O
of	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
in	O
patients	O
.	O

Our	O
observations	O
suggest	O
that	O
cannabis	O
use	I:C3160814
is	O
associated	O
with	O
lower	O
prevalence	O
of	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
in	O
patients	O
.	O

These	O
novel	O
findings	B:C0243095
suggest	O
additional	O
molecular	O
mechanistic	I:C0947630
studies	I:C0947630
to	O
explore	O
the	O
potential	O
role	O
of	O
cannabis	O
use	I:C3160814
in	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
development	O
.	O

These	O
novel	O
findings	O
suggest	O
additional	O
molecular	B:C0947630
mechanistic	I:C0947630
studies	I:C0947630
to	O
explore	O
the	O
potential	O
role	O
of	O
cannabis	O
use	I:C3160814
in	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
development	O
.	O

These	O
novel	O
findings	O
suggest	O
additional	O
molecular	O
mechanistic	I:C0947630
studies	I:C0947630
to	O
explore	O
the	O
potential	O
role	O
of	O
cannabis	B:C3160814
use	I:C3160814
in	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
development	O
.	O

These	O
novel	O
findings	O
suggest	O
additional	O
molecular	O
mechanistic	I:C0947630
studies	I:C0947630
to	O
explore	O
the	O
potential	O
role	O
of	O
cannabis	O
use	I:C3160814
in	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
development	O
.	O

These	O
novel	O
findings	O
suggest	O
additional	O
molecular	O
mechanistic	I:C0947630
studies	I:C0947630
to	O
explore	O
the	O
potential	O
role	O
of	O
cannabis	O
use	I:C3160814
in	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
development	B:C0243107
.	O

